 |
Diabetes cases in Mena ‘likely to soar 110pc by 2045’The number of diabetic patients in the Mena region is expected to increase by 110 per cent to 82 million by 2045, second only to Africa (156 per cent), said a new report by Colliers International. This would significantly impact m More… |
 |
Diabetes, Vitamin D Deficiency linked in EmiratisThe unprecedentedly high prevalence of Type 2 Diabetes Mellitus (T2DM) among Emiratis may be linked to a genetic inability to metabolize Vitamin D properly, research at Abu Dhabi’s Khalifa University has indicated. “Th More… |
 |
mHealth models to drive cardiometabolic marketNew business models such as direct-to-consumer (DTC) and telemonitoring services are supporting market players in reaching larger patient bases across the global cardiometabolic diseases landscape, a report said. Growth partnershi More… |
|
mHealth models to drive cardiometabolic marketNew business models such as direct-to-consumer (DTC) and telemonitoring services are supporting market players in reaching larger patient bases across the global cardiometabolic diseases landscape, a report said. Growth partnershi More… |
 |
NCDs 'responsible for 65pc deaths in UAE'The non-communicable diseases (NCDs) constitute a huge burden and a major public health issue in UAE accounting for 65 per cent of deaths across the country, said a top health expert at an indutsry event in Dubai, UAE. Addressing More… |
 |
Diabetes prevalence highest among expats in MEAThe Middle East and Africa (MEA) region showed the highest prevalence of diabetes among expatriate population globally at 2.58 per cent in 2016, according to a new report. Meanwhile, the total number of members with diabetes incre More… |
 |
Frontline leadership ‘key to better healthcare’The region’s healthcare issues like diabetes can be tackled better by giving leadership training and power to those at the frontline of diabetes care and bringing them together for voluntary leadership roles, an industry expert said. More… |
 |
Neopharma invests $237m towards diabetes management in GCCNeopharma, a leading pharmaceutical manufacturing company, has invested a total of BD90 million ($237 million) in a state-of-the-art Japanese factory that will manufacture supplements for patients in the pre-diabetic stage and also Type II diabe More… |
 |
Holmusk to showcase digital diabetes management programHolmusk, a global digital health and data analytics company headquartered in Singapore, will present GlycoLeap, a digital diabetes management programme, at the World Innovation Summit for Health (WISH) in Doha, Qatar. The Innovati More… |
 |
Sanofi and Alphabet set up JV in diabetesFrench drugmaker Sanofi and Google owner Alphabet's US-based life sciences company Verily, announced on Monday the launch of a joint-venture aimed at offering patients suffering from diabetes products that will combine devices and services. More… |
